Acronis’ Mid-Year Cyberthreats Report Finds Ransomware is the Number-One Threat to Organizations, Projects Damages to exceed $30 Billion by 2023

Increasing complexity in IT continues to lead to breaches and compromises highlighting the need for more holistic approaches to Cyber Protection

Acronis research unveils the top-10 most commonly impersonated brands in phishing emails.

The Acronis Mid-Year Cyberthreats Report 2022 found that brands such as DHL and Microsoft are the most commonly impersonated in phishing emails.

SCHAFFHAUSEN, Switzerland, Aug. 24, 2022 (GLOBE NEWSWIRE) — Today, Acronis, a global leader in cyber protection, unveiled its mid-year cyberthreats report, conducted by Acronis’ Cyber Protection Operation Centers, to provide an in-depth review of the cyberthreat trends the company’s experts are tracking. The report details how ransomware continues to be the number one threat to large and medium-sized businesses, including government organizations, and underlines how over-complexity in IT and infrastructure leads to increased attacks. Nearly half of all reported breaches during the first half of 2022 involved stolen credentials, which enable phishing and ransomware campaigns. Findings underscore the need for more holistic approaches to cybersecurity.

To extract credentials and other sensitive information, cybercriminals use phishing and malicious emails as their preferred infection vectors. Nearly one percent of all emails contain malicious links or files, and more than one-quarter (26.5%) of all emails were delivered to the user’s inbox (not blocked by Microsoft365) and then were removed by Acronis email security.

Moreover, the research reveals how cybercriminals also use malware and target unpatched software vulnerabilities to extract data and hold organizations hostage. Further complicating the cybersecurity threat landscape is the proliferation of attacks on non-traditional entry avenues. Attackers have made cryptocurrencies and decentralized finance systems a priority of late. Successful breaches using these various routes have resulted in the loss of billions of dollars and terabytes of exposed data.

These attacks are able to be launched due to overcomplexity in IT, a common problem throughout businesses as many tech leaders assume more vendors and programs lead to improved security when the inverse is actually true. Increased complexity exposes more surface area and gaps to potential attackers, keeping organizations vulnerable to potentially devastating damage.

“Today’s cyberthreats are constantly evolving and evading traditional security measures,” said Candid Wüest, Acronis VP of Cyber Protection Research. “Organizations of all sizes need a holistic approach to cybersecurity that integrates everything from anti-malware to email-security and vulnerability-assessment capabilities. Cybercriminals are becoming too sophisticated and the results of attacks too dire to leave it to single-layered approaches and point solutions.”

Critical data points reveal complex threat landscape
As reliance on the cloud increases, attackers have homed in on different entryways to cloud-based networks. Cybercriminals increased their focus on Linux operating systems and managed service providers (MSPs) and their network of SMB customers. The threat landscape is shifting, and companies must keep pace.

Ransomware is worsening, even more so than we predicted.

  • Ransomware gangs, like Conti and Lapsus$, are inflicting serious damage.
  • The Conti gang demanded $10 million in ransom from the Costa Rican government and has published much of the 672 GB of data it stole.
  • Lapsus$ stole 1 TB of data and leaked credentials of over 70,000 NVIDIA users. The same gang also stole 30 GB worth of T-Mobile’s source code.
  • The U.S. Department of State is concerned, offering up to $15 million for information about the leadership and co-conspirators of Conti.

The use of phishing, malicious emails and websites, and malware continues to grow.

  • Six hundred malicious email campaigns made their way across the internet in the first half of 2022.
  • 58% of the emails were phishing attempts.
  • Another 28% of those emails featured malware.
  • The business world is increasingly distributed, and in Q2 2022, an average of 8.3% of endpoints tried to access malicious URLs.

More cybercriminals are focusing on cryptocurrencies and decentralized finance (DeFi) platforms. By exploiting flaws in smart contracts or stealing recovery phrases and passwords with malware or phishing attempts, hackers have wormed their way into crypto wallets and exchanges alike.

  • Cyberattacks have contributed to a loss of more than $60 billion in DeFi currency since 2012.
  • $44 billion of that vanished during the last 12 months.

Unpatched vulnerabilities of exposed services is another common infection vector—just ask Kaseya. To that end, companies like Microsoft, Google, and Adobe have emphasized software patches and transparency around publicly submitted vulnerabilities. These patches likely helped stem the tide of 79 new exploits each month. Unpatched vulnerabilities also tie into how overcomplexity is hurting businesses more than helping, as all of these vulnerabilities serve as additional potential points of failure.

Breaches leave financial, SLA distress in their wake
Cybercriminals often demand ransoms or outright steal funds from their targets. But companies do not suffer challenges only to their bottom lines. Attacks often cause downtime and other service-level breaches, impacting a company’s reputation and customer experience.

  • In 2021 alone, the FBI attributed a total loss of $2.4 billion to business email compromise (BEC).
  • Cyberattacks caused more than one-third (36%) of downtime in 2021.

The current cybersecurity threat landscape requires a multi-layered solution that combines anti-malware, EDR, DLP, email security, vulnerability assessment, patch management, RMM, and backup capabilities all in one place. The integration of these various components gives companies a better chance of avoiding cyberattacks, mitigating the damage of successful attacks, and retaining data that might have been altered or stolen in the process.

You can download a copy of the full Acronis Mid-Year Cyberthreats Report 2022 here or you can learn more here.

About Acronis:

Acronis unifies data protection and cybersecurity to deliver integrated, automated cyber protection that solves the safety, accessibility, privacy, authenticity, and security (SAPAS) challenges of the modern digital world. With flexible deployment models that fit the demands of service providers and IT professionals, Acronis provides superior cyber protection for data, applications, and systems with innovative next-generation antivirus, backup, disaster recovery, and endpoint protection management solutions powered by AI. With advanced anti-malware powered by cutting-edge machine intelligence and blockchain based data authentication technologies, Acronis protects any environment – from cloud to hybrid to on premises – at a low and predictable cost.

Founded in Singapore in 2003 and incorporated in Switzerland in 2008, Acronis now has more than 2,000 employees in 34 locations in 19 countries. Acronis Cyber Protect solution is available in 26 languages in over 150 countries and is used by over 20,000 service providers to protect over 750,000 businesses.

Press contacts:
Karl Bateson
+617 306 6275
Karl.Bateson@acronis.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9f49cf4f-3c5a-4f4d-9105-14872774652c


Nikkiso Clean Energy & Industrial Gases Group Wins Multiple Hydrogen Fueling Station Contracts in California and South Korea

TEMECULA, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) — Nikkiso Clean Energy & Industrial Gases Group (“CE&IG”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is proud to be the recipient of multiple contracts to provide over a dozen Hydrogen Fueling Stations (“HFS”) to customers in California and South Korea. These stations, intended to be operational between Q4 2023 and Q2 2024, cover fueling stations for light-duty, heavy-duty, and transit fuel cell vehicles that need H35 and H70 dispensing.

“As an ambassador member of the California Fuel Cell Partnership (“CaFCP”) and core leader of cryogenic technology, Nikkiso is key in connecting the hydrogen ecosystem to advance the clean energy agenda,” said Peter Wagner, CEO of Nikkiso CE&IG.

“We are pleased to offer flexible and scalable commercial and technical offers where our customers need us the most: from equipment fabricator to turnkey EPC solutions,” said Joseph Pak, President of the Nikkiso Integrated Cryogenic Solutions.

The purchase orders have a combined value of almost US$60 million. Nikkiso has dedicated over 150,000 ft2 (14,000 m2) square feet of floor space to mass produce hydrogen fueling stations in Murrieta, CA, Escondido, CA, Busan, S. Korea, and Neuenbürg, Germany. Every station will be manufactured to comply with the local content requirements, including the Buy America Act for the US Hydrogen Hub market.

Starting with these hydrogen station projects, the Nikkiso Group aims to further expand their hydrogen-related business by strengthening their participation in the hydrogen supply chain and expanding into the global market.

About Nikkiso Clean Energy & Industrial Gases Group
Nikkiso’s CE&IG is part of the Nikkiso Co., Ltd group of companies. Nikkiso Co. is a $1.4B public company. CE&IG comprises five distinct functional units: Cryogenic Pumps (ACD, Nikkiso Cryo), Process Systems (Cosmodyne), Heat Exchanger Systems (Cryoquip), Cryogenic Services (through 20 global facilities) and Integrated Cryogenic Solutions (providing centralized management of products and project development). In 2020, CE&IG expanded its capabilities further with the acquisition of what was GP- Strategies’ Alternative Fuels Division. This addition provides yet another major manufacturing facility in Southern California. Acknowledged as a market leader in the design, engineering, manufacturing, construction and maintenance of Cryogenic infrastructure, this facility offers full in-house capabilities from engineering & permitting through manufacturing, construction, and maintenance.

For over 50 years, Nikkiso has been a leader in the Clean Energy industry and are leading the change to a healthier world. With our hydrogen fueling technology, Nikkiso has become a leader in the evolving hydrogen revolution, including a project on the world’s first LH2 bunkering facility. For more information visit www.NikkisoCEIG.com.

For more information, please visit www.nikkisoCEIG.com and www.nikkiso.com.

MEDIA CONTACT:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com

Ebola Vaccinations in East Congo to Start on Thursday After New Case

An Ebola vaccination campaign will start in the Congolose city of Beni on Thursday after a new case of the virus was confirmed this week, the World Health Organization said on Wednesday.

More than 200 vaccine doses have been arrived in Beni, in the east of Democratic Republic of Congo, it said.

The latest confirmed case has been genetically linked to a 2018-2020 outbreak in North Kivu and Ituri provinces, which claimed nearly 2,300 lives.

Six people were killed in another flare-up from that same outbreak last year.

A WHO spokesman told Reuters the shots were provided by the organization and that inoculations would start on Thursday.

Congo’s dense tropical forests are a natural reservoir for the Ebola virus, which causes fever, body aches, and diarrhea, and can linger in the body of survivors only to resurface years later.

The vast central African country has recorded 14 outbreaks since 1976. The 2018-2020 outbreak in the east was Congo’s largest and the second largest ever recorded, with nearly 3,500 total cases.

Congo’s most recent outbreak was in northwest Equateur province. Itwas declared over in July after five deaths.

Source: Voice of America

Patients in India Protest Shortage of Life-Saving HIV Drugs

A group of HIV-positive people has been protesting for more than a month at the central office of India’s National AIDS Control Organization, or NACO, in New Delhi, demanding a regular supply of life-saving antiretroviral therapy — also known as ART — drugs across the country.

NACO is the nodal organization of the government of India that manages programs for the prevention and control of HIV and AIDS in the country. ART drugs work by stopping the virus from replicating in HIV-infected people, helping them live longer and reducing or stopping the infection of the virus to others.

Centers that supply ART drugs across India have been out of stock on several antiretroviral drugs for months, threatening the lives and well-being of hundreds of thousands of HIV patients, according to leaders of the group that has been protesting in Delhi since July 21.

“I have been getting distress calls from hundreds of HIV-infected persons from different states of the country reporting the shortage in supply of the ART drugs from the ART centers across the country,” Hari Shankar, a leader of the ongoing Delhi protest, told VOA.

“The crisis has been acute since April. Most of them cannot afford to buy the drugs from the market privately,” Shankar added. “We will not withdraw from this protest until they, all across the country, start receiving the ART drugs supply regularly.”

According to a government estimate, India has 2.3 million people living with HIV. In 2004, the government began providing free ART to the people living with HIV in the country. Now around 1.5 million HIV patients are dependent on the ART provided by the government.

NACO procures ART drugs and distributes them through more than 675 ART centers spread across the country. People undergoing ART visit the centers every one, two or three months to collect their drugs. But since April, the supply of the drugs has been irregular in many parts of the country, many people said.

“Earlier, we regularly used to get the stock of the drugs for one to three months. Now we get the drugs just for three or five days. The ART centers even in some big hospitals in New Delhi are turning us away because of the shortage of the drugs,” said Shankar, a member of the Delhi Network of Positive People or DNP Plus, which works to facilitate better medical treatment for people living with HIV/AIDS in New Delhi.

The Delhi protest demanding a regular supply of ART drugs across the country is organized by DNP Plus.

Nisha Jha, another DNP Plus member, said that many people across the country are reporting a shortage of Dolutegravir (DTG) 50 mg, a key ART drug, from the ART centers.

“Those HIV patients who have been on the first line, second line, or third line ART for years, and are also infected with tuberculosis, need to take DTG 50 separately,” Jha told VOA.

“Because of the crisis of DTG, lives of thousands of our PLHIV brothers and sisters are in jeopardy now.”

There is a crisis of drugs like Nevirapine, Ritonavir, Lopinavir, Abacavir, and Zidovudine — which are used in different ART regimens for HIV ¬patients — at ART centers across the country, Jha added.

The ART centers are asking patients to change their drug regimens because of the shortages of some drugs, many people said.

Surmick Waribam, a leader of HIV patients group Manipur Network of Positive People, or MNP Plus, in the northeastern state of Manipur, said the normal protocol calls for HIV patients to undergo certain medical tests before their ART regimens are changed.

“The ART centers are asking HIV patients to change the regimens without conducting any such medical tests. The patients are scared to change the regimen, fearing adverse impacts on their health. Being very poor, most of them cannot afford to buy the drugs from the market. So, they are left with no option but to change the regimen,” Waribam told VOA.

In response to a query from VOA, Dr. Manisha Verma, a spokesperson for the Indian health ministry, said in an emailed statement that there is “adequate stock for around 95% [of HIV patients] in India.”

“There is no stock-out of drugs and there are no instances of disruptions or non-availability of treatment services or ARV medicines at the national and state levels,” Verma said.

Dr. Mothi SN, an HIV and AIDS specialist, said that since the global roll-out of ARV medicines began in 2004, the HIV/AIDS scenario changed from being a “rapidly progressing fatal illness” to that of “a chronic manageable illness like diabetes or hypertension with a near-normal life expectancy.”

“Regular intake of ARV medicines and prompt adherence to treatment are resulting in added years of life. People with HIV may survive the infection and finally die of other age-related diseases like stroke, heart disease, cancer, etc.,” Mysore-based Mothi told VOA.

“To achieve the optimum outcome, prompt adherence to uninterrupted ARV therapy becomes the cornerstone of management of people living with AIDS.”

Waribam from Manipur said the shortage in supply of his regular ARV drugs forced him to switch to a new regimen of drugs.

“For my ARV drugs, I am dependent solely on the ART center. So, in June, like most of around 14,000 [people living with HIV] in Manipur, I agreed to switch to the new drugs the ART center offered. Even then, the ART centers are giving us drugs for three, five or 10 days,” Waribam said.

“Like thousands of others, I am also anxious and in doubt, if the new drugs would succeed to keep my viral load under check and not cause any damage to my health. …The authorities are playing with the lives of the PLHIV.”

Source: Voice of America